Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Rocky--Thank you!!!eom
My guess is the fee was nominal--- as I recall ACTC was desperate at that time for funds
Invest-123--thank you for both your recent posts-eom
You get the Crystal Ball award for today--at the moment we are green. I was afraid to come home to my wife when it was down 16%
Thank you Rocky for being the voice of reason-eom
I dod not see terren listed??
Thanks and I love this line in particular--"As each of the trials will be open-label, the company may, once the trials commence, be able to share details on the safety profile and response of the patients prior to the end of the trials." GLTA
Old article--but surprised me--eom
ACTC/Dr Lanza article-Kidney breakthrough 'could end the need for donors'by JAMES CHAPMAN, Daily Mail
Comments (0) Add to My Stories Scientists have created the world's first test-tube organs in a breakthrough that could revolutionise transplant medicine.
The American experts are claiming to have used cloning technology to transform cells taken from a cow's ear into functioning kidneys.
The 'spare-part' kidneys were genetically identical to the cell donor and so were not rejected when they were transplanted into the animal.
The scientists are confident that the same technique will work in humans within the next few years.
Using just a few skin cells, doctors would be able to grow perfectly matched organs with none of the problems of rejection associated with donor tissue.
They have already started trying to produce other tissues, including heart cells.
The team of scientists at Advanced Cell Technologies in Massachusetts, a private firm, attracted international controversy when they announced the creation of the world's first human embryo clones late last year.
Dr Robert Lanza, who led the team, said last night that the latest experiments proved that cloning techniques could offer a viable source of transplant tissue for humans.
In the UK, an estimated 100,000 people suffer from some form of severe kidney disease.
The NHS carries out approximately 1,200 kidney transplants a year, but almost 6,000 patients are waiting for a new organ at any one time.
Hundreds die before organs become available and at least 32,000 require treatment such as dialysis.
Dr Lanza, ACT's vice-president of medical and scientific development, said cloned human embryos could be harvested for replacement tissues to treat everything from Parkinson's disease to heart failure within the next few years.
He said of the experiment on cow tissue: 'This is the first demonstration of creating a functioning organ using cloning technology. It is a big step forward. If, as seems likely, this applies to humans too it will be an incredibly important breakthrough.'
The researchers, who will publish details of their work in a scientific journal shortly, started by removing a single skin cell from the ear of an adult cow.
This was then fused with a donated cow egg which had been hollowed out so that its DNA - the blueprint for life - was removed.
When this was jolted with electricity, it became an embryo rich in so- called stem cells - the body's 'mother' cells which have the potential to develop into any of the body tissues. Because they come from a cloned embryo, the cells were genetically identical to the donor animal, ensuring that any tissue produced from them would not be rejected.
The scientists cultured the stem cells so that they became kidney cells, using chemical treatments that the company is currently keeping secret. The cells were grown on a biodegradable kidney-shaped scaffold designed by experts at Harvard Medical School.
The scientists produced several miniature kidneys each a couple of inches long. These were transplanted back into the adult animal, alongside its existing organs, where they started to produce urine.
'When we took the organs out a few months later, they were working just as we had hoped,' Dr Lanza said.
'We can create a functioning organ by growing on scaffolds. There were absolutely no problems with rejection.
'This is one of a series of experiments we have done which demonstrate the potential of therapeutic cloning.
'In adult cows, we are creating new heart tissue using the same techniques.
'We are also trying to create cells to treat arthritis. Every kind of replacement cell is imaginable.'
Many scientists and doctors believe creating cloned human embryos to be mined for 'spare part' body tissues will offer exciting and unprecedented medical opportunities.
But the Roman Catholic Church and pro-life campaigners, who regard early-stage embryos as forms of human life, are against such research.
Scientists will be able to create and then destroy life in the laboratory on an unprecedented scale, they argue. They are also concerned about the ethics of allowing human creation without conception for the first time.
There are also fears that by publishing details of their techniques, scientists will give other rogue experts the chance to produce a cloned human baby.
Several teams have said they have already started work on such projects, though until today many scientists doubted they had the know-how.
In the UK, the creation of cloned embryos to produce cells for medical treatments has been given the green light. Full reproductive cloning, which would lead to the birth of a cloned human baby, remains illegal.
Kidney breakthrough 'could end the need for donors'by JAMES CHAPMAN, Daily Mail
Comments (0) Add to My Stories Scientists have created the world's first test-tube organs in a breakthrough that could revolutionise transplant medicine.
The American experts are claiming to have used cloning technology to transform cells taken from a cow's ear into functioning kidneys.
The 'spare-part' kidneys were genetically identical to the cell donor and so were not rejected when they were transplanted into the animal.
The scientists are confident that the same technique will work in humans within the next few years.
Using just a few skin cells, doctors would be able to grow perfectly matched organs with none of the problems of rejection associated with donor tissue.
They have already started trying to produce other tissues, including heart cells.
The team of scientists at Advanced Cell Technologies in Massachusetts, a private firm, attracted international controversy when they announced the creation of the world's first human embryo clones late last year.
Dr Robert Lanza, who led the team, said last night that the latest experiments proved that cloning techniques could offer a viable source of transplant tissue for humans.
In the UK, an estimated 100,000 people suffer from some form of severe kidney disease.
The NHS carries out approximately 1,200 kidney transplants a year, but almost 6,000 patients are waiting for a new organ at any one time.
Hundreds die before organs become available and at least 32,000 require treatment such as dialysis.
Dr Lanza, ACT's vice-president of medical and scientific development, said cloned human embryos could be harvested for replacement tissues to treat everything from Parkinson's disease to heart failure within the next few years.
He said of the experiment on cow tissue: 'This is the first demonstration of creating a functioning organ using cloning technology. It is a big step forward. If, as seems likely, this applies to humans too it will be an incredibly important breakthrough.'
The researchers, who will publish details of their work in a scientific journal shortly, started by removing a single skin cell from the ear of an adult cow.
This was then fused with a donated cow egg which had been hollowed out so that its DNA - the blueprint for life - was removed.
When this was jolted with electricity, it became an embryo rich in so- called stem cells - the body's 'mother' cells which have the potential to develop into any of the body tissues. Because they come from a cloned embryo, the cells were genetically identical to the donor animal, ensuring that any tissue produced from them would not be rejected.
The scientists cultured the stem cells so that they became kidney cells, using chemical treatments that the company is currently keeping secret. The cells were grown on a biodegradable kidney-shaped scaffold designed by experts at Harvard Medical School.
The scientists produced several miniature kidneys each a couple of inches long. These were transplanted back into the adult animal, alongside its existing organs, where they started to produce urine.
'When we took the organs out a few months later, they were working just as we had hoped,' Dr Lanza said.
'We can create a functioning organ by growing on scaffolds. There were absolutely no problems with rejection.
'This is one of a series of experiments we have done which demonstrate the potential of therapeutic cloning.
'In adult cows, we are creating new heart tissue using the same techniques.
'We are also trying to create cells to treat arthritis. Every kind of replacement cell is imaginable.'
Many scientists and doctors believe creating cloned human embryos to be mined for 'spare part' body tissues will offer exciting and unprecedented medical opportunities.
But the Roman Catholic Church and pro-life campaigners, who regard early-stage embryos as forms of human life, are against such research.
Scientists will be able to create and then destroy life in the laboratory on an unprecedented scale, they argue. They are also concerned about the ethics of allowing human creation without conception for the first time.
There are also fears that by publishing details of their techniques, scientists will give other rogue experts the chance to produce a cloned human baby.
Several teams have said they have already started work on such projects, though until today many scientists doubted they had the know-how.
In the UK, the creation of cloned embryos to produce cells for medical treatments has been given the green light. Full reproductive cloning, which would lead to the birth of a cloned human baby, remains illegal.
Kidney breakthrough 'could end the need for donors'by JAMES CHAPMAN, Daily Mail
Comments (0) Add to My Stories Scientists have created the world's first test-tube organs in a breakthrough that could revolutionise transplant medicine.
The American experts are claiming to have used cloning technology to transform cells taken from a cow's ear into functioning kidneys.
The 'spare-part' kidneys were genetically identical to the cell donor and so were not rejected when they were transplanted into the animal.
The scientists are confident that the same technique will work in humans within the next few years.
Using just a few skin cells, doctors would be able to grow perfectly matched organs with none of the problems of rejection associated with donor tissue.
They have already started trying to produce other tissues, including heart cells.
The team of scientists at Advanced Cell Technologies in Massachusetts, a private firm, attracted international controversy when they announced the creation of the world's first human embryo clones late last year.
Dr Robert Lanza, who led the team, said last night that the latest experiments proved that cloning techniques could offer a viable source of transplant tissue for humans.
In the UK, an estimated 100,000 people suffer from some form of severe kidney disease.
The NHS carries out approximately 1,200 kidney transplants a year, but almost 6,000 patients are waiting for a new organ at any one time.
Hundreds die before organs become available and at least 32,000 require treatment such as dialysis.
Dr Lanza, ACT's vice-president of medical and scientific development, said cloned human embryos could be harvested for replacement tissues to treat everything from Parkinson's disease to heart failure within the next few years.
He said of the experiment on cow tissue: 'This is the first demonstration of creating a functioning organ using cloning technology. It is a big step forward. If, as seems likely, this applies to humans too it will be an incredibly important breakthrough.'
The researchers, who will publish details of their work in a scientific journal shortly, started by removing a single skin cell from the ear of an adult cow.
This was then fused with a donated cow egg which had been hollowed out so that its DNA - the blueprint for life - was removed.
When this was jolted with electricity, it became an embryo rich in so- called stem cells - the body's 'mother' cells which have the potential to develop into any of the body tissues. Because they come from a cloned embryo, the cells were genetically identical to the donor animal, ensuring that any tissue produced from them would not be rejected.
The scientists cultured the stem cells so that they became kidney cells, using chemical treatments that the company is currently keeping secret. The cells were grown on a biodegradable kidney-shaped scaffold designed by experts at Harvard Medical School.
The scientists produced several miniature kidneys each a couple of inches long. These were transplanted back into the adult animal, alongside its existing organs, where they started to produce urine.
'When we took the organs out a few months later, they were working just as we had hoped,' Dr Lanza said.
'We can create a functioning organ by growing on scaffolds. There were absolutely no problems with rejection.
'This is one of a series of experiments we have done which demonstrate the potential of therapeutic cloning.
'In adult cows, we are creating new heart tissue using the same techniques.
'We are also trying to create cells to treat arthritis. Every kind of replacement cell is imaginable.'
Many scientists and doctors believe creating cloned human embryos to be mined for 'spare part' body tissues will offer exciting and unprecedented medical opportunities.
But the Roman Catholic Church and pro-life campaigners, who regard early-stage embryos as forms of human life, are against such research.
Scientists will be able to create and then destroy life in the laboratory on an unprecedented scale, they argue. They are also concerned about the ethics of allowing human creation without conception for the first time.
There are also fears that by publishing details of their techniques, scientists will give other rogue experts the chance to produce a cloned human baby.
Several teams have said they have already started work on such projects, though until today many scientists doubted they had the know-how.
In the UK, the creation of cloned embryos to produce cells for medical treatments has been given the green light. Full reproductive cloning, which would lead to the birth of a cloned human baby, remains illegal.
Read more: http://www.dailymail.co.uk/news/article-97207/Kidney-breakthrough-end-need-donors.html#ixzz1EgycqNFeKidney breakthrough 'could end the need for donors'by JAMES CHAPMAN, Daily Mail
Comments (0) Add to My Stories Scientists have created the world's first test-tube organs in a breakthrough that could revolutionise transplant medicine.
The American experts are claiming to have used cloning technology to transform cells taken from a cow's ear into functioning kidneys.
The 'spare-part' kidneys were genetically identical to the cell donor and so were not rejected when they were transplanted into the animal.
The scientists are confident that the same technique will work in humans within the next few years.
Using just a few skin cells, doctors would be able to grow perfectly matched organs with none of the problems of rejection associated with donor tissue.
They have already started trying to produce other tissues, including heart cells.
The team of scientists at Advanced Cell Technologies in Massachusetts, a private firm, attracted international controversy when they announced the creation of the world's first human embryo clones late last year.
Dr Robert Lanza, who led the team, said last night that the latest experiments proved that cloning techniques could offer a viable source of transplant tissue for humans.
In the UK, an estimated 100,000 people suffer from some form of severe kidney disease.
The NHS carries out approximately 1,200 kidney transplants a year, but almost 6,000 patients are waiting for a new organ at any one time.
Hundreds die before organs become available and at least 32,000 require treatment such as dialysis.
Dr Lanza, ACT's vice-president of medical and scientific development, said cloned human embryos could be harvested for replacement tissues to treat everything from Parkinson's disease to heart failure within the next few years.
He said of the experiment on cow tissue: 'This is the first demonstration of creating a functioning organ using cloning technology. It is a big step forward. If, as seems likely, this applies to humans too it will be an incredibly important breakthrough.'
The researchers, who will publish details of their work in a scientific journal shortly, started by removing a single skin cell from the ear of an adult cow.
This was then fused with a donated cow egg which had been hollowed out so that its DNA - the blueprint for life - was removed.
When this was jolted with electricity, it became an embryo rich in so- called stem cells - the body's 'mother' cells which have the potential to develop into any of the body tissues. Because they come from a cloned embryo, the cells were genetically identical to the donor animal, ensuring that any tissue produced from them would not be rejected.
The scientists cultured the stem cells so that they became kidney cells, using chemical treatments that the company is currently keeping secret. The cells were grown on a biodegradable kidney-shaped scaffold designed by experts at Harvard Medical School.
The scientists produced several miniature kidneys each a couple of inches long. These were transplanted back into the adult animal, alongside its existing organs, where they started to produce urine.
'When we took the organs out a few months later, they were working just as we had hoped,' Dr Lanza said.
'We can create a functioning organ by growing on scaffolds. There were absolutely no problems with rejection.
'This is one of a series of experiments we have done which demonstrate the potential of therapeutic cloning.
'In adult cows, we are creating new heart tissue using the same techniques.
'We are also trying to create cells to treat arthritis. Every kind of replacement cell is imaginable.'
Many scientists and doctors believe creating cloned human embryos to be mined for 'spare part' body tissues will offer exciting and unprecedented medical opportunities.
But the Roman Catholic Church and pro-life campaigners, who regard early-stage embryos as forms of human life, are against such research.
Scientists will be able to create and then destroy life in the laboratory on an unprecedented scale, they argue. They are also concerned about the ethics of allowing human creation without conception for the first time.
There are also fears that by publishing details of their techniques, scientists will give other rogue experts the chance to produce a cloned human baby.
Several teams have said they have already started work on such projects, though until today many scientists doubted they had the know-how.
In the UK, the creation of cloned embryos to produce cells for medical treatments has been given the green light. Full reproductive cloning, which would lead to the birth of a cloned human baby, remains illegal.
Kidney breakthrough 'could end the need for donors'by JAMES CHAPMAN, Daily Mail
Comments (0) Add to My Stories Scientists have created the world's first test-tube organs in a breakthrough that could revolutionise transplant medicine.
The American experts are claiming to have used cloning technology to transform cells taken from a cow's ear into functioning kidneys.
The 'spare-part' kidneys were genetically identical to the cell donor and so were not rejected when they were transplanted into the animal.
The scientists are confident that the same technique will work in humans within the next few years.
Using just a few skin cells, doctors would be able to grow perfectly matched organs with none of the problems of rejection associated with donor tissue.
They have already started trying to produce other tissues, including heart cells.
The team of scientists at Advanced Cell Technologies in Massachusetts, a private firm, attracted international controversy when they announced the creation of the world's first human embryo clones late last year.
Dr Robert Lanza, who led the team, said last night that the latest experiments proved that cloning techniques could offer a viable source of transplant tissue for humans.
In the UK, an estimated 100,000 people suffer from some form of severe kidney disease.
The NHS carries out approximately 1,200 kidney transplants a year, but almost 6,000 patients are waiting for a new organ at any one time.
Hundreds die before organs become available and at least 32,000 require treatment such as dialysis.
Dr Lanza, ACT's vice-president of medical and scientific development, said cloned human embryos could be harvested for replacement tissues to treat everything from Parkinson's disease to heart failure within the next few years.
He said of the experiment on cow tissue: 'This is the first demonstration of creating a functioning organ using cloning technology. It is a big step forward. If, as seems likely, this applies to humans too it will be an incredibly important breakthrough.'
The researchers, who will publish details of their work in a scientific journal shortly, started by removing a single skin cell from the ear of an adult cow.
This was then fused with a donated cow egg which had been hollowed out so that its DNA - the blueprint for life - was removed.
When this was jolted with electricity, it became an embryo rich in so- called stem cells - the body's 'mother' cells which have the potential to develop into any of the body tissues. Because they come from a cloned embryo, the cells were genetically identical to the donor animal, ensuring that any tissue produced from them would not be rejected.
The scientists cultured the stem cells so that they became kidney cells, using chemical treatments that the company is currently keeping secret. The cells were grown on a biodegradable kidney-shaped scaffold designed by experts at Harvard Medical School.
The scientists produced several miniature kidneys each a couple of inches long. These were transplanted back into the adult animal, alongside its existing organs, where they started to produce urine.
'When we took the organs out a few months later, they were working just as we had hoped,' Dr Lanza said.
'We can create a functioning organ by growing on scaffolds. There were absolutely no problems with rejection.
'This is one of a series of experiments we have done which demonstrate the potential of therapeutic cloning.
'In adult cows, we are creating new heart tissue using the same techniques.
'We are also trying to create cells to treat arthritis. Every kind of replacement cell is imaginable.'
Many scientists and doctors believe creating cloned human embryos to be mined for 'spare part' body tissues will offer exciting and unprecedented medical opportunities.
But the Roman Catholic Church and pro-life campaigners, who regard early-stage embryos as forms of human life, are against such research.
Scientists will be able to create and then destroy life in the laboratory on an unprecedented scale, they argue. They are also concerned about the ethics of allowing human creation without conception for the first time.
There are also fears that by publishing details of their techniques, scientists will give other rogue experts the chance to produce a cloned human baby.
Several teams have said they have already started work on such projects, though until today many scientists doubted they had the know-how.
In the UK, the creation of cloned embryos to produce cells for medical treatments has been given the green light. Full reproductive cloning, which would lead to the birth of a cloned human baby, remains illegal.
Read more: http://www.dailymail.co.uk/news/article-97207/Kidney-breakthrough-end-need-donors.html#ixzz1EgycqNFe
Read more: http://www.dailymail.co.uk/news/article-97207/Kidney-breakthrough-end-need-donors.html#ixzz1EgycqNFe
Read more: http://www.dailymail.co.uk/news/article-97207/Kidney-breakthrough-end-need-donors.html#ixzz1EgycqNFe
The questions you ask have been answered a long time ago on this bd
Thanks again-eom
"NIH is considering additional funding for blastomere-derived lines" is taken from Rabin's 4th slide from the presentation a few days ago--is it a fact? I want to believe it is a fact since Rabin put it on slide and said it in public--but I do have a bias and so does Rabin.
How sure of this are we?--thanks
Thank you--eom
"NIH proposing expanded funding to accomodate act's blastomere-derived lines" The fourth slide -fifth bullet. I want to believe that this is new --but I believe that I have it heard before??? comments/thouhgts anyone--thank you in advance
As far as actc is concerned, the combined knowledge,expertise,etc. provided by members of this bd and the g bd (not including my limited abilities) are far superior than this report could ever offer. ...and you are right --$3450 of actc stock is worth a lot more than the report--jmho
Hell is correct!eom
Not sure if first link is correct--http://secfilings.com/searchresultswide.aspx?link=2&filingid=7728376
More actc shares issued--http://www.sec.gov/Archives/edgar/data/1140098/000101376211000371/forms1.htm
Hawks-welcome and good luck to you--signed, hopeful in harlem
Thanks rocky-looking forward to it--I assume Rabin is presenting and am hoping he will add some info-- would love to hear about a patient/start date. I know, I know, I know (and you are right)----getting way ahead of myself again...glta
Once again thank u rocky eom
Cirm meeting is today--optimistic people are hoping for a loan to be given to ACTC----wrong/misleading/self serving info should not be posted --although it is VERY obvious--
THANK U- I LIKE THE WAY U THINK--EOM
Good week coming--WHY?eom
Sorry to say - this is just a cheap rehash of old news by someone poorly informed even with a new date on it--appreciate your effort and posting it and glta
THANK YOU--YOU HAVE ELIMINATED A LOT STUPID ASSUMPTIONS ON MY PART AND GAVE ME REALITY/CLARITY ABOUT A LOT OF THINGS THAT I MISINTERPRETED. THANK YOU!!!! harlem
I am happy to see green after the past few days--glta
Intersting how those who do not like this stock/own this stock post "VALUABLE INSIGHTS" for the investors. Their concern for our well being is amazing. GL to all my fellow ACTC investors/believers--hopefully a financial return will come our way --but more important--the science will help those in need of it!!!!
Ruff -well put-GLTA
That is why u are one of the posters i look for on this bd.GL
We are in agreement-Your post is great and I wish you well!!!
Ison--Thank u and GL eom
IMO-Stay long and strong-predictions of lows and highs are absurd. The recent FDA approval has attracted bashers and pumpers. if anyone could REALLY predict a pps, they would be step agead of W Buffet and not on this bd posting. Disclosure: own a bunch and holding for the long term. GLTA longs and beware of the trolls
Is ten dollars a share (just to use a number mentioned in another post) or five dollars a share unreasonable if most or all of the 12 patients in the trial are helped by Actc. I am not looking for a crystal ball answer but would appreciate any input from those more knowledgeable-- what is the worth/mkt cap for a company that succeeds in stopping/potentially reversing blindness for millions of people? Perhaps i am being too simplistic, but if Lanza helped some rats with human cells-- I expect that he can do the smae for people. gotta be worth a fortune???Please forgive my lack of financial/scientic expertise--I make no claims as a financial/scientific guru--just wondering though? Thank you and GLTA longs
JMHO-- this stock is manipulated like many others.
The pipeline is fantastic--eyes, heart, blood--wow--jmho
Thank u for the facts. I geta a little carried with actc-eom
Thank u for the facts. I geta a little carried with actc-eom
I'm hoping for a new nugget of info-eg. first patient(s) enrolled and dare I dream -- the start date for the first patient. GLTA and thank you to all the great people who post here!!